Freitag Julien Ben, Barnard Adele
Prahran Sports Medicine Centre, Lifecare, Prahran, Victoria, Australia.
BMJ Case Rep. 2013 Mar 26;2013:bcr2012007463. doi: 10.1136/bcr-2012-007463.
To evaluate the effect of combining photo-activation therapy with platelet-rich plasma injections for the novel treatment of osteoarthritis.
We present a case report of osteoarthritis of the knee treated with photo-activated platelet-rich plasma injections (PAPRP).
After utilising conventional osteoarthritis treatment methods a patient underwent a course of PAPRP injections. The patient outcome was measured using the numerical pain rating scale (NPRS) and the Western Ontario and McMaster Universities Arthritis (WOMAC) Index.
Following treatment the patient reported improvements in both pain and function as measured by the NPRS and WOMAC Index, respectively. The patient was followed up for 18 weeks, at which time no significant complications were noted.
In this case report of osteoarthritis, with strict control of conventional therapy variables, PAPRP injections demonstrated improvement in all recorded outcome measures. The results of this case report highlight the need to further investigate the use of PAPRP in the treatment of symptomatic knee osteoarthritis.
评估光激活疗法联合富血小板血浆注射对骨关节炎的新型治疗效果。
我们呈现了一例采用光激活富血小板血浆注射(PAPRP)治疗膝骨关节炎的病例报告。
在使用传统骨关节炎治疗方法后,一名患者接受了一个疗程的PAPRP注射。使用数字疼痛评分量表(NPRS)和西安大略和麦克马斯特大学骨关节炎指数(WOMAC)对患者的治疗效果进行评估。
治疗后,患者分别通过NPRS和WOMAC指数报告了疼痛和功能的改善。对患者进行了18周的随访,在此期间未发现明显并发症。
在本骨关节炎病例报告中,在严格控制传统治疗变量的情况下,PAPRP注射在所有记录的疗效指标上均显示出改善。本病例报告的结果凸显了进一步研究PAPRP在有症状膝骨关节炎治疗中应用的必要性。